Viatris Inc (VTRS): Net Income
-$3.51B
Year ended 2025-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.51B | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$634.20M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $54.70M | -97.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $2.08B | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$1.27B | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$669.90M | n/m | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $16.80M | -95.2% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $352.50M | n/a | 2021-03-01, From 2018-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Viatris Inc (VTRS) | 2025-12-31 | -$3.51B | n/m |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $4.50B | +2.1% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $3.95B | n/m |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.41B | n/m |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $120.00M | n/m |
| Zoetis Inc. (ZTS) | 2025-12-31 | $2.67B | +7.5% |
| Organon & Co. (OGN) | 2025-12-31 | $187.00M | -78.4% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $286.93M | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | -$232.00M | n/m |
Compare VTRS, REGN, VRTX, TEVA side by side · Screen every company in Pharmaceutical Preparations ↗